| [1] GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990-2015:a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet Neurol, 2017, 16:877-897.
[2] Dorsett M, Liang SY. Diagnosis and treatment of central nervous system infections in the emergency department[J]. Emerg Med Clin North Am, 2016, 34:917-942.
[3] Khatib U, van de Beek D, Lees JA, Brouwer MC. Adults with suspected central nervous system infection:a prospective study of diagnostic accuracy[J]. J Infect, 2017, 74:1-9.
[4] Xu HD, Diao HM, Zhu XL, Geng DQ, Wang H. Etiological and clinical characteristics of acute meningitis[J]. Zhonghua Yi Yuan Gan Ran Xue Za Zhi, 2021, 31:1102-1106.[许海东, 刁红梅, 朱晓莉, 耿德勤, 王皓. 急性脑膜炎病原学及临床特征[J]. 中华医院感染学杂志, 2021, 31:1102-1106.]
[5] Guan HZ, Li W, Guo SG, Zhu Y, Wang JW. The challenge of identification and diagnosis of emerging viral encephalitis[J]. Zhonghua Yi Xue Za Zhi, 2020, 100:1921-1924.[关鸿志, 李玮,郭守刚, 朱沂, 王佳伟. 重视新发病毒性脑炎的识别与诊断[J]. 中华医学杂志, 2020, 100:1921-1924.]
[6] Neurology Society of Chinese Medical Association. Expert consensus on diagnosis and treatment of autoimmune encephalitis in China[J]. Zhonghua Shen Jing Ke Za Zhi, 2017, 50:91-98.[中华医学会神经病学分会. 中国自身免疫性脑炎诊治专家共识[J]. 中华神经科杂志, 2017, 50:91-98.]
[7] Wang JW, Liu L. Hot issues and challenges of autoimmune encephalitis[J]. Zhonghua Shen Jing Ke Za Zhi, 2016, 49:4-7.[王佳伟, 刘磊. 自身免疫性脑炎的热点问题及其面临的挑战[J]. 中华神经科杂志, 2016, 49:4-7.]
[8] Zhao C, Li ZY. Research progress of myelin oligodendrocyte glycoprotein antibody related diseases[J]. Zhongguo Shen Jing Mian Yi Xue He Shen Jing Bing Xue Za Zhi, 2021, 28:71-74.[赵聪, 李柱一. 髓鞘少突胶质细胞糖蛋白抗体相关疾病研究进展[J]. 中国神经免疫学和神经病学杂志, 2021, 28:71-74.]
[9] Neuroimmunity Branch of Chinese Society of Immunology. Chinese experts consensus on the diagnosis and treatment of diseases related to anti-myelin oligodendrocyte glycoprotein immunoglobulin G antibodies[J]. Zhongguo Shen Jing Mian Yi Xue He Shen Jing Bing Xue Za Zhi, 2020, 27:86-95.[中国免疫学会神经免疫分会. 抗髓鞘少突胶质细胞糖蛋白免疫球蛋白G抗体相关疾病诊断和治疗中国专家共识[J]. 中国神经免疫学和神经病学杂志, 2020, 27:86-95.]
[10] Iorio R, Damato V, Evoli A, Gessi M, Gaudino S, Di Lazzaro V, Spagni G, Sluijs JA, Hol EM. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity:a case series of 22 patients[J]. J Neurol Neurosurg Psychiatry, 2018, 89:138-146.
[11] De Virgilio A, de Vincentiis M, Inghilleri M, Fabrini G, Conte M, Gallo A, Rizzo MI, Greco A. Idiopathic hypertrophic pachymeningitis:an autoimmune IgG4-related disease[J]. Immunol Res, 2017, 65:386-394.
[12] Nosadini M, Mohammad SS, Corazza F, Ruga EM, Kothur K, Perilongo G, Frigo AC, Toldo I, Dale RC, Sartori S. Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis:a systematic literature review with analysis of 43 cases[J]. Dev Med Child Neurol, 2017, 59:796-805.
[13] Armangue T, Spatola M, Vlagea A, Mattozzi S, Cárceles-Cordon M, Martinez-Heras E, Llufriu S, Muchart J, Erro ME, Abraira L, Moris G, Monros-Giménez L, Corral-Corral Í, Montejo C, Toledo M, Bataller L, Secondi G, Ariño H, Martínez-Hernández E, Juan M, Marcos MA, Alsina L, Saiz A, Rosenfeld MR, Graus F, Dalmau J; Spanish Herpes Simplex Encephalitis Study Group. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis:a prospective observational study and retrospective analysis[J]. Lancet Neurol, 2018, 17:760-772.
[14] Rössling R, Prüss H. SOP:antibody-associated autoimmune encephalitis[J]. Neurol Res Pract, 2020, 2:1. |